Please provide your email address to receive an email when new articles are posted on . To avoid uncertainty, an expert recommends physicians understand each vaccine’s serotypes and which ones are ...

Clinical trials and meta-analyses examining the efficacy of pneumococcal polysaccharide vaccine (Pneumovax 23®) in adults have produced conflicting data. This Viewpoint discusses a study designed to ...

Human antibodies to bacterial polyaaccharides consist primarily of IgG and are largely restricted to the IgG2 subclass. We examined the ontogeny of the IgG subclass response to pneumococcal ...

Dublin, June 27, 2019 (GLOBE NEWSWIRE) -- The "V114" report has been added to ResearchAndMarkets.com's offering. Merck & Co's V114 is a 15-valent pneumococcal capsular polysaccharide conjugate vaccine ...